comparemela.com

Latest Breaking News On - Erik manting - Page 1 : comparemela.com

Mendus : Interim Report January - March 2024

English Swedish .

Erik mantingLotta fermNorthx biologics northLymphoma groupHuman research ethics committeeNorthx biologicsAustraliasian leukaemiaInnate killerAnnual innate killer cell summit

Mendus : Invitation to presentation of Mendus first quarter report 2024

Mendus : Invitation to presentation of Mendus first quarter report 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Lotta fermErik mantingFriday may

Mendus provides business update and outlook for vididencel program

Press Release Stockholm, Sweden, March 12, 2024 ADVANCE II Phase 2 trial data provide basis for late-stage development of lead product vididencel in acute myeloid leukemiaRegistration trial.

United statesErik mantingLymphoma groupAmerican society for hematologyNorthx biologicsBusiness updateAmerican societyAustralian leukemiaInderes event studioNasdaq stockholm

Mendus to participate in upcoming industry conferences

Press release Stockholm, Sweden, February 27, 2024 Mendus AB , a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the.

New yorkUnited statesSan diegoComunidad autonoma de catalunaErik mantingResearch satwinder kaur singhBio europe springKiller summitInnate killerProcess development trackNasdaq stockholmConferences feb march

Mendus to hold Business Update event on March 12

23.02.2024 - Press Release Stockholm, Sweden, February 23, 2024 Mendus AB (“Mendus” publ; IMMU.ST), will hold an in-person and live-streamed business update event in Stockholm on March 12, 15:00-17:00 CET to discuss the company’s latest pipeline .

Erik mantingLymphoma groupNorthx biologicsInderes event studioMendus chartEndus kursEndus aktie

vimarsana © 2020. All Rights Reserved.